Ambroxol Trial Shows Safety and Biomarker Stabilization in Parkinson’s Dementia

Published in JAMA Neurology, the trial results support a larger cognition-focused study this year to test Ambroxol’s neuroprotective potential in Parkinson’s-related dementia.